European Union

Video Webinar: Taiwan's Bicycle Manufacturers Align With the Global Industry for a Sustainable Future

Retrieved on: 
Wednesday, December 8, 2021
Taiwan External Trade Development Council, Union, European Union, Awareness, TBA, Carbon, TAITRA, Motor vehicle, European Economic and Trade Office, CO2, Industry, Renewable energy

TAIPEI, Dec. 8, 2021 /PRNewswire/ -- The goal of achieving net zero emissions is becoming increasingly important for the cycling industry.

Key Points: 
  • TAIPEI, Dec. 8, 2021 /PRNewswire/ -- The goal of achieving net zero emissions is becoming increasingly important for the cycling industry.
  • To discuss this topic, Taipei Cycle invited industry leaders and professionals to a virtual webinar.
  • Taipei Cycle 2022 will be a hybrid show, both physical (running from 9-12 March) and online (9 March to 8 April).
  • Gina Chang, the Secretary General of the Taiwan Bicycle Association (TBA), discussed several trends that will affect the industry over the next ten years.

Entrust Expands Cloud Security Services Footprint in Europe and Beyond With nShield as a Service

Retrieved on: 
Wednesday, December 8, 2021
Software, Technology, Security, Cloud, European Union, AWS, CSPS, Service, PKI, Common Criteria, HSM, Union, WebSocket, Organization, Google Cloud, Amazon Web Services, Provin, Blockchain, Criterion, Azure, Senior, Attention, General manager, Ford Torino engine specifications, Solution, FIPS, Compliance, Microsoft, Digital identity, Cryptocurrency, Video game console

Entrust nShield as a Service was initially launched in 2019 with datacenters located in the UK and the US.

Key Points: 
  • Entrust nShield as a Service was initially launched in 2019 with datacenters located in the UK and the US.
  • Entrust nShield as a Service delivers the same functionality as on-premises nShield HSMs, in a subscription-based solution.
  • The expansion of nShield as a Service, which is part of an Entrust global outreach, addresses the security needs of cloud markets worldwide.
  • The unique nShield Security World key management architecture enforces important separation of duties with dual controls that segregate security functions from administrative responsibilities.

Video Webinar: Taiwan's Bicycle Manufacturers Align With the Global Industry for a Sustainable Future

Retrieved on: 
Wednesday, December 8, 2021
Taiwan External Trade Development Council, European Union, Awareness, Carbon, CO2, Union, TAITRA, Industry, TBA, Motor vehicle, Multimedia, European Economic and Trade Office, Renewable energy

TAIPEI, Dec. 8, 2021 /PRNewswire/ -- The goal of achieving net zero emissions is becoming increasingly important for the cycling industry.

Key Points: 
  • TAIPEI, Dec. 8, 2021 /PRNewswire/ -- The goal of achieving net zero emissions is becoming increasingly important for the cycling industry.
  • To discuss this topic, Taipei Cycle invited industry leaders and professionals to a virtual webinar.
  • Taipei Cycle 2022 will be a hybrid show, both physical (running from 9-12 March) and online (9 March to 8 April).
  • Gina Chang, the Secretary General of the Taiwan Bicycle Association (TBA), discussed several trends that will affect the industry over the next ten years.

Chargebee Continues Global Expansion with Office and Data Center in Australia

Retrieved on: 
Tuesday, December 7, 2021
Cloud, European Union, International Safe Harbor Privacy Principles, APP, Growth, CEO, A Cloud Guru, Organization, Gartner, European Union vs. Google, Partnership, General Data Protection Regulation, E-commerce, Adoption, IOT, SAN, Seven Seas, Compliance, GDPR, Software as a service

SAN FRANCISCO, Dec. 7, 2021 /PRNewswire/ -- Chargebee , the leading subscription management platform, announced it has opened a dedicated office and data center in Sydney, Australia to support SaaS and subscription businesses and ensure APP compliance.

Key Points: 
  • SAN FRANCISCO, Dec. 7, 2021 /PRNewswire/ -- Chargebee , the leading subscription management platform, announced it has opened a dedicated office and data center in Sydney, Australia to support SaaS and subscription businesses and ensure APP compliance.
  • The announcement comes after recent growth as Chargebee expands its global customer base and offerings to help businesses around the world simplify revenue growth and finance operations.
  • Many countries have passed strict data sovereignty laws, requiring that data not only be stored but processed in the country of origin.
  • Similar to the European Union's General Data Protection Regulation ("GDPR'), Australia has Australian Privacy Principles ("APPs"), which require that companies above a certain size that do business in Australia must store and process all data in Australia.

Transaction in Own Shares

Retrieved on: 
Tuesday, December 7, 2021
European Union, Company, Withdrawal, Listing Rules, Union, Royal Dutch Shell, Market abuse, European Union (Withdrawal) Act 2018, European Union (Withdrawal Agreement) Act 2020, Online gambling

These share purchases form part of the Company's share buy-back arrangement previously announced on 02 December 2021.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 02 December 2021.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 02 December 2021 up to and including 28 January 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70

Finn Partners Continues To Expand Global Reach With Irish Acquisition

Retrieved on: 
Tuesday, December 7, 2021
European Union, Public relations, Twitter, Chantal, ESG, Health, Technology, Heart, Growth, Culture, Union, Leadership, 360, Philosophy, PR, Partnership, EMEA, Government, Creativity, Partner (business rank), Time, Chief executive officer, Foodservice, FDI, Public affairs, Instagram, Marketing, Acquisition, Management, Airline

Dan Pender, founder of 360, will become Managing Partner, 360, a FINN Partners Company, and will report to Chantal Bowman-Boyles, Managing Partner, EMEA.

Key Points: 
  • Dan Pender, founder of 360, will become Managing Partner, 360, a FINN Partners Company, and will report to Chantal Bowman-Boyles, Managing Partner, EMEA.
  • Dan will collaborate with the existing FINN Partners public affairs team to further strengthen its public affairs capabilities in the EU.
  • Since founding FINN Partners almost ten years ago, we have grown our global footprint from six to 25 offices on three continents.
  • It was apparent from early-on in our discussions with FINN Partners that there was a real fit.

Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health

Retrieved on: 
Tuesday, December 7, 2021
Ethos, HIPAA, Twitter, Risk, Eye, Vitality, DSY, Vertical auto profile, Mydriasis, Discovery, CEO, Diabetes, Diabetic retinopathy, CE, Health Insurance Portability and Accountability Act, Diagnosis, Stroke, Compliance, Algorithm, AIA, GLOBE, JSE Limited, Glaucoma, Union, Food, Artificial intelligence, Patient, NIH, General Data Protection Regulation, Discovery Health, CCO, LinkedIn, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, AI, GDPR, Medtech, European Union, Collection, Government, FDA, Health Canada, Food and Drug Administration, Retina, DHMS, NHS, PDF, Accountability Act, Risk assessment, CPT, Discovery Limited, Medical device, Health insurance

Discovery Health has always focused on incentivising, simplifying and enhancing member access to evidence-based preventative healthcare screening, says CEO of Discovery Health, Dr. Ryan Noach.

Key Points: 
  • Discovery Health has always focused on incentivising, simplifying and enhancing member access to evidence-based preventative healthcare screening, says CEO of Discovery Health, Dr. Ryan Noach.
  • Frank Cheng, Eyenuk President and CCO, added, We applaud Discovery Healths leadership for being the first payor to bring our EyeArt AI system to South Africa.
  • The EyeArt AI System is the most extensively validated and adopted AI system for autonomous diabetic retinopathy detection in real-world settings.
  • Vertice EyeCare is excited to offer the cutting-edge EyeArt AI system in South Africa.

DIALOG Pursues Global Patents for Structural System to Bring Mass Timber Technology to High Rise Buildings

Retrieved on: 
Tuesday, December 7, 2021
European Union, Council on Tall Buildings and Urban Habitat, Environment, DIALOG, Carbon, Research, Fast Company, Health, Wood, Culture, Contract, Union, HTFS, Steel, Industry, Partnership, Transport, Education, Council, CLT, Skyscraper, Timber recycling, Patent, EllisDon, Partner, Materials science, Hybrid, AIA, Engineered wood

Once approved, the system could lead to the introduction of mass timber structural solutions into the supertall tower category, thus significantly reducing the environmental impact of tall building development in high density urban areas.

Key Points: 
  • Once approved, the system could lead to the introduction of mass timber structural solutions into the supertall tower category, thus significantly reducing the environmental impact of tall building development in high density urban areas.
  • The patents have been filed by the international design firm in Canada, the United States, the European Union, Australia and China.
  • The Hybrid Timber Floor System (HTFS) combines cross-laminated timber panels with steel, and concrete to build high rise towers with a significantly reduced carbon footprint.
  • While awaiting patent approval, DIALOG is working in partnership with global construction firm EllisDon to develop scaled panels for thorough structural testing.

Pharvaris Announces Changes to its Board of Directors

Retrieved on: 
Tuesday, December 7, 2021
European Union, U.S. Securities and Exchange Commission, Mera, Medicine, Company, GLOBE, HAE, Security (finance), Union, Drug development, Patient, Metabolism, Chalmers University of Technology, Hereditary angioedema, COVID-19, Uppsala University, Intellectual property, AstraZeneca, Biopharmaceutical, Annual report, Investment, Pharmaceutical industry

Dr. Bjrk will replace Martijn Kleijwegt, who has stepped down from the board effective December 1 to focus on new investments.

Key Points: 
  • Dr. Bjrk will replace Martijn Kleijwegt, who has stepped down from the board effective December 1 to focus on new investments.
  • Elisabeth is joining the Pharvaris board at an important time for the company as we prepare for clinical data to read out in the next year from Phase 2 clinical studies in both prophylactic and on-demand HAE, said David Meeker, M.D., chair of Pharvaris board of directors.
  • Her expertise in drug development, ranging from discovery to launch, aligns with the clinical progress made by Pharvaris this year.
  • Elisabeths addition to the board will expand our existing expertise, and positions Pharvaris well as we prepare for commercialization in the coming years.

Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma

Retrieved on: 
Tuesday, December 7, 2021
European Union, Aggressive lymphoma, Medicine, Forward-looking statement, GLOBE, B-cell lymphoma, Drug Quality and Security Act, European Commission, Therapy, PALO, Ovarian cancer, MYC, Form 10-K, Mantle cell lymphoma, Union, Failure, FIH, Patient, Royal commission, 8-K, Biomarker, Securities Exchange Act of 1934, Cancer, Securities Act of 1933, COVID-19, Diagnosis, Nasdaq, Society, Pharmaceutical industry, Risk management

The granting of Orphan Drug Designation for VIP152 in DLBCL realizes another significant regulatory milestone for Vincerx, said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx.

Key Points: 
  • The granting of Orphan Drug Designation for VIP152 in DLBCL realizes another significant regulatory milestone for Vincerx, said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx.
  • Vincerx is currently advancing Phase 1b studies of VIP152 in MYC-driven relapsed or refractory aggressive lymphomas and advanced solid tumors.
  • Arm 1 will enroll up to 40 patients with relapsed/refractory aggressive lymphoma, including DLBCL, transformed follicular lymphoma, and mantle cell lymphoma.
  • Forward-looking statements speak only as of the date hereof, and Vincerx disclaims any obligation to update any forward-looking statements.